Adenosquamous carcinoma
MONDO:0006074A carcinoma composed of malignant glandular cells and malignant squamous cells.
Also known as: adenosquamous carcinoma, adenosquamous carcinoma (morphologic abnormality), carcinoma, adenosquamous, malignant, mixed adenocarcinoma and epidermoid carcinoma, mixed adenocarcinoma and epidermoid cell carcinoma, mixed adenocarcinoma and squamous carcinoma, mixed adenocarcinoma and squamous cell carcinoma
2792 clinical trials for this condition and its sub-types, 8 tagged with Adenosquamous carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Adenosquamous carcinoma
-
Cervical adenosquamous carcinoma 16 trials
1 sub-type
-
Pancreatic adenosquamous carcinoma 13 trials
-
Adenosquamous lung carcinoma 5 trials
-
Esophageal adenosquamous carcinoma 3 trials
-
Endometrial adenosquamous carcinoma 2 trials
-
Adenosquamous breast carcinoma 0 trials
-
Adenosquamous prostate carcinoma 0 trials
-
Colorectal adenosquamous carcinoma 0 trials
2 sub-types
- Adenosquamous colon carcinoma 0 trials
- Rectal adenosquamous carcinoma 0 trials
-
Gallbladder adenosquamous carcinoma 0 trials
-
Gastric adenosquamous carcinoma 0 trials
-
Liver adenosquamous carcinoma 0 trials
1 sub-type
-
Skin adenosquamous carcinoma 0 trials
-
Thymic adenosquamous carcinoma 0 trials
Most studied deeper sub-types
-
Could your own tumor cells beat lung cancer? new trial tests it
Disease control Recruiting nowThis study takes white blood cells from a patient's lung tumor, grows them in large numbers in the lab, and gives them back to the patient to fight the cancer. The goal is to see if these specially selected cells can shrink tumors in people with advanced non-small cell lung cance…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Lymph node surgery may boost cervical cancer treatment
Disease control Recruiting nowThis study looks at whether surgically removing para-aortic lymph nodes before standard chemoradiation can improve disease-free survival in people with stage IIIC1 cervical cancer. About 510 participants will be randomly assigned to either standard treatment or surgery plus tailo…
Phase 3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental immune therapy aims to tackle HPV cancers before standard care
Disease control Recruiting nowThis study tests whether a single infusion of a patient's own genetically engineered immune cells (E7 TCR-T cells) can shrink or eliminate HPV-related cancers before the patient receives standard treatment like chemo-radiation or surgery. The trial enrolls 15 adults with advanced…
Phase 1/2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug combo aims to fight Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis Phase 2 trial is testing whether two drugs, pembrolizumab and lenvatinib, can shrink or control vulvar cancer that cannot be surgically removed. About 80 participants will receive the combination in 21-day cycles. The study will measure tumor response and track side effects.
Phase 2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC